Target intelligence / Profile preview

RNA, U6 small nuclear 1232, pseudogene (RNU6-1232P)

Target
RNU6-1232P
Molecular classification
Pseudogene, Non-coding RNA, Processed pseudogene, Small nuclear RNA-derived pseudogene
01

Overview

RNU6-1232P is a pseudogene derived from the U6 small nuclear RNA (snRNA) gene. U6 snRNA itself is a highly conserved, short non-coding RNA critical for mRNA splicing via the spliceosome, but pseudogene copies such as RNU6-1232P lack protein-coding ability and are considered non-functional relics formed through retrotransposition mechanisms such as LINE-1 (L1) activity. These pseudogenes are widespread in the human genome and serve as markers of retrotransposition dynamics, but are not known to encode functional RNA or protein products, nor do they serve as receptors, enzymes, or other therapeutically relevant molecular targets. Key notes: - This entry describes a processed pseudogene of U6 snRNA, not an active or functional gene or therapeutic target, so it is not suitable for drug targeting, biomarker development, or disease association studies. - If the query presupposed a molecular target, this is incorrect, as RNU6-1232P is a pseudogene and not used in clinical, pharmacological, or research targeting contexts. - No canonical functional protein or active RNA product is encoded, so all target-relevant fields are null or not applicable. - The most scientifically accurate name is "RNA, U6 small nuclear 1232, pseudogene" with abbreviation "RNU6-1232P". If more information on the functional U6 snRNA (not pseudogene) is needed, it is involved in the spliceosome and catalyzes the excision of introns from pre-mRNA in the nucleus, but the pseudogene version RNU6-1232P is not active.

Other names
RNU6-1232PRNA, U6 snRNA pseudogene 1232
02

Mechanism of action

None (not a therapeutic target)

03

Biological functions

None (pseudogene, not known to have endogenous biological function)
04

Disease associations

None documented (not associated with disease processes or targeted in therapy)
05

Safety considerations

None
06

Interacting drugs

None (no drugs interact with this pseudogene)
07

Biomarkers

None (no known biomarker use)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1232, pseudogene (RNU6-1232P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1232, pseudogene (RNU6-1232P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call